Loading annual review details
Conagra Brands, Inc. (CAG)FY2026 investor yearly review
Across FY2026’s four calls, management anchored the year on restoring and sustaining volume in frozen and snacks while running a disciplined supply-chain and productivity program. Revenue stayed under prior levels, cash generation remained positive but weaker, and the year closed with a clearer emphasis on margin stabilization through prudent pricing, elasticity management, and investment pacing.
Overall investor read
Execution-sensitive volume-to-margin transition
Calls repeatedly tied near-term profitability to volume investments, with margin outcomes depending on productivity, pricing elasticity, and supply stability.
Primary financial signal
Gross margin held near 24% while operating margin fell sharply
FY2026 gross margin was stable, but operating margin and net income were pressured, aligning with management’s inflation and reinvestment narrative.
Primary call signal
Q2 pricing + elasticities were the recurring hinge
From Q1 through Q4 Q&A, management framed pricing timing, tariff/inflation offsets, and productivity as the key swing factors.
Headline outcomes for revenue, profitability, and cash generation.
Revenue
Revenue declined; year aligned with ongoing volume investment trade-offs.
Gross margin
Gross margin held, despite inflation and reinvestment pressure.
Operating margin
Operating margin fell sharply, reflecting cost and reinvestment pressure.
Net income
Net income sharply lower year over year.
Operating cash flow
Operating cash flow declined; cash focus remained a management priority.
Free cash flow
Free cash flow down year over year, but still positive.
Free cash flow margin
FCF margin stayed in a mid-single-to-high range despite pressure.
Net debt
Net debt remained elevated; divestiture proceeds and deleveraging themes persisted.
Management focused FY2026 on frozen/snacks volume recovery and supply resilience, but margins lagged—pricing elasticity and productivity became the key stabilizers.
Consumer demand & mix
Across Q1 to Q4 Q&A, management repeatedly returned to volume recovery as the priority—citing service restoration, stronger promotional availability, and innovation pipelines. Analysts tested whether shipment versus consumption and competitors’ pricing behavior would derail the recovery.
Margin quality
Quarter-by-quarter materiality and tone for annual transcript themes.
Scroll horizontally to see more columns.
| Theme | Q1 | Q2 | Q3 | Q4 | Next monitor |
|---|---|---|---|---|---|
| Frozen and snacks volume momentum supported by service recovery and innovation | Positive Service recovery lifted share and frozen volumes as products returned to shelves. |
FY2026 showed encouraging volume/service progress and persistent cash focus, but margin and earnings were pressured by inflation, tariff phasing, and reinvestment timing.
In Q1 management linked improved in-market performance to returning products and restoring merchandising, including share gains across frozen categories and 98% service levels. This kept the year’s volume narrative intact despite volatility.
Across Q1 to Q4, management emphasized productivity and tariff mitigation, with Q2 and Q4 reinforcing productivity targets as the mechanism to defend margins. Q3 described robust productivity momentum into the year’s exit.
Quarterly signals showed volume recovery in frozen/snacks early, a mid-year cash and margin hinge, and a year-end framing around pricing, productivity, and reinvestment pacing.
Margins pressured, conversion remained a discipline
Product breakdown bars are scaled against the largest annual revenue item; labels show revenue, YoY change, and revenue share.
The year began with service-driven frozen recovery and inflation/tariff pressure, moved into a second-half momentum framework anchored by pricing and working-capital discipline, and finished with a margin-and-elasticity plan supported by reinvestment and portfolio simplification priorities.
Management emphasized that improved service levels translated into in-market share progress and frozen volume momentum, while Q1 affordability pressures from inflation and tariffs kept profitability under strain.
Read earnings transcriptIn Q&A, management leaned on shipment timing normalization, wrapping prior-year supply constraints, and expectation of positive second-half organic sales growth. They also set up how tariff and absorption could pressure operating margin.
Key items investors likely monitored as management translated volume recovery into sustainable profitability.
Elasticity outcomes directly influence whether pricing translates into margin without volume damage.
Listen for updated language on elasticities by frozen and grocery/snacks categories and any plan tweaks in Q&A.
Productivity execution was repeatedly framed as the primary lever when inflation exceeds productivity.
Watch for productivity benchmark commentary (including >4%) and whether productivity savings flow through to margins.
From Q1 onward, management quantified inflation pressure and tariff-related costs, while emphasizing productivity and tariff mitigation as offsets. Q2 discussed cost-to-volume assumptions and Q3/Q4 framed productivity targets and elasticity prudence as the path to margin stabilization.
Pricing power
Management consistently described targeted pricing—especially in can products and cocoa-related items—while keeping promotions “reasonable and high-quality.” In Q4, they highlighted higher-than-historical elasticities baked into plans and named elasticity monitoring as a top top-line variable.
Cash generation
Q1 flagged seasonal working capital impacts and inventory rebuilding; Q2 and Q3 repeatedly tied guidance credibility to working capital diligence. Q3 explicitly connected free cash flow conversion to inventory reduction acceleration, supported by technology and supply planning.
Momentum into the second half; December delayed shipments supported positive outlook.
Positive Management leaned on two-year frozen momentum and innovation velocity strength. |
Positive Commitment to frozen stayed firm despite margin reinvestment. |
| Track frozen and snacks share, service-level commentary, and innovation shipment progress each quarter. |
| Inflation/tariff pressure vs productivity mitigation | Negative Inflation and tariff costs stayed elevated; proteins remained the largest headwind. | Mixed Tariff cost phasing raised Q2 margin pressure, with productivity expected to offset. | Mixed Management framed agility for inflation scenarios while maintaining productivity focus. | Mixed Q1 margin pressure tied to inflation flow-through and tariff wrap; productivity targeted >4%. | Watch commentary on core inflation vs productivity, and quarterly tariff/wrap phasing details in earnings Q&A. |
| Pricing actions and elasticity assumptions as the top-line hinge | Mixed Disclosed margin lever management including steel-driven pricing expectations for Q2. | Positive Management defended not rolling back list price; volume inflection looked efficient. | Mixed Pricing described as surgical, with elasticities labeled encouraging after actions. | Mixed Elasticities assumed higher than historical; pricing timing expected to drive Q2 improvements. | Monitor frozen elasticity language, volume-down assumptions, and any elasticity misses tied to pricing rollouts. |
| Supply-chain resiliency investments and working capital execution | Positive 98% service levels and productivity gains supported the service recovery narrative. | Positive Working-capital diligence and transition of baked chicken modernization on track. | Positive Free cash flow conversion narrative emphasized inventory reduction acceleration. | Positive Service levels and inventory/working capital markers named as key supply-chain metrics. | Track service levels (98%+) and inventory/working-capital reduction milestones alongside supply modernization updates. |
| Capital allocation and leverage targets shaping reinvestment pacing | Neutral Divestitures funded net debt reduction; guidance reaffirmed amid inflation risk. | Neutral Management kept EPS range wider due to volatility; emphasized cash flow coverage. | Neutral Free cash flow conversion target referenced; alignment between supply chain and finance emphasized. | Mixed Dividend reduction framed as enabling investments while progressing toward leverage target. | Monitor leverage/deleveraging commentary, dividend and cash flow trade-offs, and any changes in investment step-ups. |
| Portfolio simplification and complexity reduction | Neutral Portfolio reshape and SKU simplification framed as medium-to-long term work. | Watch Investor Day sequencing and progress on SKU rationalization themes and portfolio strategy updates. |
Management consistently described pricing as targeted and paired with promotion, rather than broad list-price rollbacks. Q4 framed higher-than-historical elasticities in the plan, making elasticity monitoring a disciplined management focus.
Management discussed working-capital rebuild impacts in Q1 and then tied cash conversion to inventory reduction in Q3. Q4 reiterated inventory/working-capital as supply-chain efficiency markers.
Despite gross margin stability, FY2026 operating margin and net income were significantly lower. Management’s Q&A connected this to inflation exceeding productivity at points and reinvestment timing rather than purely one-off items.
Q1 and Q2 emphasized inflation/tariff headwinds, while Q4 specifically cited wrap amounts over-indexing to Q1. The year narrative required investors to treat phasing as a central variable.
Management referenced absorption headwinds tied to inventory rebuilding and supply-chain modernization, including Q2 expectations for Q3 A&P and absorption. Investors had to account for operational “puts and takes” in modeling.
Management emphasized prudent elasticity assumptions, but multiple Q&A threads asked how pricing might interact with volume and competition. Q4 elevated elasticity as the most important top-line variable to monitor.
Scroll horizontally to see more columns.
| Quarter | Revenue | YoY revenue growth | Diluted EPS | Gross margin | Investor read |
|---|---|---|---|---|---|
| Q1Aug-25 | $2.63B | -5.4% | $0.34 | 24.3% | Management tied Q1 improvement to service recovery and share gains, while reaffirming full-year guidance amid elevated inflation and tariff exposure. |
| Q2Nov-25 | $2.98B | 13.2% | $-1.39 | 23.4% | Second-half momentum helped justify guidance, despite absorption and tariff/cost phasing concerns. |
| Q3Feb-26 | $2.79B | -6.4% | $0.42 | 23.6% | Cash flow conversion and inventory reduction were highlighted alongside margin-building drivers for Q4. |
| Q4May-26 | $2.88B | 3.4% | $-3.37 | 24.3% | Margin trajectory depended on pricing phasing and productivity, supported by reinvestment and supply-chain markers. |
Management reinforced a volume-first strategy with frozen/snacks momentum, while repeatedly tying margin expectations to productivity, surgical pricing with encouraging elasticities, and operational confidence around shipments matching consumption over the year.
Read earnings transcriptQ4 centered on the margin trajectory: Q1 op margin under pressure from inflation and tariff wrap, then improving through pricing phasing and productivity. Capital allocation (dividend cut) was framed as enabling supply-chain resilience investments.
Read earnings transcriptCash conversion relied on inventory reduction progress, which affected free cash flow variability across quarters.
Track inventory and working capital markers, including inventory days/dollars commentary and cash conversion updates.
Service performance was named as a clean indicator for delivering products on time, supporting volume realization.
Monitor quarterly service level targets (98% to 98.5%) and any mentions of supply interruptions risk.
Complexity reduction and portfolio reshape are positioned as execution-critical to fund profitable growth investments.
Watch sequencing around SKU rationalization progress and any Investor Day updates in early 2027 commentary.